A detailed history of Exane Derivatives transactions in Solaredge Technologies, Inc. stock. As of the latest transaction made, Exane Derivatives holds 875 shares of SEDG stock, worth $15,478. This represents 0.15% of its overall portfolio holdings.

Number of Shares
875
Previous 1,361 35.71%
Holding current value
$15,478
Previous $438,000 45.43%
% of portfolio
0.15%
Previous 0.14%

Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Jul 12, 2022

SELL
$211.92 - $335.31 $102,993 - $162,960
-486 Reduced 35.71%
875 $239,000
Q1 2022

Apr 22, 2022

BUY
$209.82 - $337.74 $19,513 - $31,409
93 Added 7.33%
1,361 $438,000
Q4 2021

Jan 28, 2022

BUY
$255.27 - $368.33 $165,925 - $239,414
650 Added 105.18%
1,268 $355,000
Q3 2021

Oct 26, 2021

SELL
$236.56 - $299.81 $1,419 - $1,798
-6 Reduced 0.96%
618 $163,000
Q2 2021

Jul 28, 2021

BUY
$204.01 - $290.14 $2,040 - $2,901
10 Added 1.63%
624 $172,000
Q1 2021

Apr 30, 2021

SELL
$246.71 - $365.97 $72,779 - $107,961
-295 Reduced 32.45%
614 $176,000
Q4 2020

Jan 27, 2021

BUY
$206.37 - $324.09 $187,590 - $294,597
909 New
909 $290,000

Others Institutions Holding SEDG

About SOLAREDGE TECHNOLOGIES, INC.


  • Ticker SEDG
  • Exchange NASDAQ
  • Sector Technology
  • Industry Solar
  • Shares Outstandng 55,635,100
  • Market Cap $984M
  • Description
  • SolarEdge Technologies, Inc., together with its subsidiaries, designs, develops, and sells direct current (DC) optimized inverter systems for solar photovoltaic (PV) installations worldwide. It operates through five segments: Solar, Energy Storage, e-Mobility, Critical Power, and Automation Machines. The company offers inverters, power optimizer...
More about SEDG
Track This Portfolio

Track Exane Derivatives Portfolio

Follow Exane Derivatives and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Exane Derivatives, based on Form 13F filings with the SEC.

News

Stay updated on Exane Derivatives with notifications on news.